Polymerase Chain Reaction (PCR) Market Report 2026

Polymerase Chain Reaction (PCR) Market Overview

• Polymerase Chain Reaction (PCR) market size has reached to $12.57 billion in 2025 • Expected to grow to $19.62 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Impact Of Personalized Medicine On The Polymerase Chain Reaction Market • Market Trend: Launch of Next-Generation qPCR System to Enhance Diagnostics Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polymerase Chain Reaction (PCR) Market?

Polymerase chain reaction (PCR) is a laboratory technique used to amplify specific segments of DNA. It involves repeated cycles of heating and cooling to denature, anneal, and extend DNA strands, resulting in the exponential amplification of the target sequence. The main types of polymerase chain reaction (PCR) are conventional polymerase chain reaction and other types. Conventional polymerase chain reaction is a laboratory technique used to amplify a specific segment of DNA through repeated cycles of heating and cooling. It is used in the diagnosis of various indications such as infectious diseases, oncology, genetic disorders, and others for medical and non-medical applications in hospitals and clinics, pharmaceutical and biotechnology industries, diagnostic centers, and academic and research organization end users.

What Is The Polymerase Chain Reaction (PCR) Market Growth Forecast?

The polymerase chain reaction (pcr) market size is expected to see strong growth in the next few years. It will grow to $19.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing adoption of point-of-care pcr testing, rising investment in precision diagnostics, expansion of decentralized laboratory testing, growing use of digital pcr for rare mutation detection, increased focus on rapid diagnostic turnaround. Major trends in the forecast period include expansion of real-time and digital pcr adoption, growing demand for high-throughput pcr testing, increasing use of pcr in oncology diagnostics, rising integration of automated pcr systems, enhanced focus on multiplex pcr assays.

Global Polymerase Chain Reaction (PCR) Market Segmentation

1) By Type: Conventional Polymerase Chain Reaction, Other Types 2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications 3) By Application: Medical, Non-Medical 4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization Subsegments: 1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr 2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr

What Is The Driver Of The Polymerase Chain Reaction (PCR) Market?

The rising demand for personalized medicine is expected to fuel the growth of the polymerase chain reaction (PCR) market going forward. Personalized medicine, also known as precision medicine, refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to tailor therapies based on individual genetic profiles. Polymerase Chain Reaction (PCR) helps personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to tailor treatment plans based on individual genetic profiles. For instance, in February 2024, the Personalized Medicine Coalition, a U.S.-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the polymerase chain reaction market.

Key Players In The Global Polymerase Chain Reaction (PCR) Market

Major companies operating in the polymerase chain reaction (pcr) market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc., Qiagen N.V., BGI Genomics Co. Ltd., Cepheid, Biocartis SA, Centogene N.V., Takara Bio Inc., LGC Biosearch Technologies, Analytik Jena AG, Promega Corporation, Meridian Bioscience Inc.

Global Polymerase Chain Reaction (PCR) Market Trends and Insights

Major companies are operating in the polymerase chain reaction (PCR) market, focusing on developing technological advancements such as real-time and digital PCR platforms to meet the rising demand for rapid diagnostics, personalized medicine, and high-throughput genetic testing. A real-time PCR (qPCR) system combines precise thermal cycling, fluorescent detection, and advanced software to quantify DNA/RNA levels, enabling more accurate and faster results compared to traditional end-point PCR, which only indicates the presence or absence of a target sequence. For instance, in November 2023, Roche, a Switzerland-based diagnostics company, launched the LightCycler PRO System, a next-generation qPCR system designed for clinical diagnostics and research. The system offers improved temperature uniformity, enhanced software algorithms, and a user-friendly interface, allowing labs to perform high-quality assays, develop custom tests, or use modular IVD research assays boosting flexibility, throughput, and accuracy in nucleic acid testing.

What Are Latest Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Market?

In April 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology company, partnered with R-Biopharm AG for an undisclosed amount. With this partnership, they aim to develop innovative PCR tests for multiresistant bacteria and strengthen their presence in the global clinical diagnostics market. R-Biopharm AG is a Germany-based biotechnology company that is involved in clinical diagnostics.

Regional Outlook

North America was the largest region in the polymerase chain reaction (PCR) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymerase Chain Reaction (PCR) Market?

The polymerase chain reaction (PCR) market consists of revenues earned by entities by providing services such as DNA amplification, gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, gene cloning, genotyping and mutation detection, pathogen detection, technical support, training, and troubleshooting assistance to researchers and laboratory professionals using their products. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction (PCR) market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, nucleotides, centrifuges, primers, pipettes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polymerase Chain Reaction (PCR) Market Report 2026?

The polymerase chain reaction (pcr) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction (pcr) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.